Skip to main content
50°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oragenics Inc
(NY:
OGEN
)
1.010
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Apr 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.010
Bid (Size)
0.4060 (1)
Ask (Size)
1.240 (7)
Prev. Close
1.010
Today's Range
1.010 - 1.010
52wk Range
1.000 - 7.740
Shares Outstanding
4,480,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
April 19, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics, Inc. Files 10K and Provides Company Update
April 01, 2024
From
Oragenics, Inc.
Via
Business Wire
Performance
YTD
-85.10%
-85.10%
1 Month
-29.37%
-29.37%
3 Month
-78.28%
-78.28%
6 Month
-70.03%
-70.03%
1 Year
-65.17%
-65.17%
More News
Read More
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
March 18, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
March 05, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics Announces Closing of Public Offering
March 01, 2024
From
Oragenics, Inc.
Via
Business Wire
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
February 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 28, 2024
Via
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Via
Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
February 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Dips 200 Points; TJX Posts Upbeat Sales
February 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
February 28, 2024
Via
InvestorPlace
Why Is Integral Ad Science (IAS) Stock Down 29% Today?
February 28, 2024
Via
InvestorPlace
Why Is Oragenics (OGEN) Stock Down 45% Today?
February 28, 2024
Via
InvestorPlace
Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket
February 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 28, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 28, 2024
Via
InvestorPlace
Oragenics Announces Pricing of Public Offering
February 27, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics Announces Proposed Public Offering
February 27, 2024
From
Oragenics, Inc.
Via
Business Wire
Oragenics, Inc. Announces Leadership Transition
February 12, 2024
From
Oragenics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 07, 2024
Via
Benzinga
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
February 07, 2024
From
Oragenics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion
February 05, 2024
From
Oragenics, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 05, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 01, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
